AU3191397A - Oxazolone derivatives and their use as anti-(helicobacter pylori) agent - Google Patents
Oxazolone derivatives and their use as anti-(helicobacter pylori) agentInfo
- Publication number
- AU3191397A AU3191397A AU31913/97A AU3191397A AU3191397A AU 3191397 A AU3191397 A AU 3191397A AU 31913/97 A AU31913/97 A AU 31913/97A AU 3191397 A AU3191397 A AU 3191397A AU 3191397 A AU3191397 A AU 3191397A
- Authority
- AU
- Australia
- Prior art keywords
- agent
- helicobacter pylori
- oxazolone derivatives
- oxazolone
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- SJHPCNCNNSSLPL-CSKARUKUSA-N (4e)-4-(ethoxymethylidene)-2-phenyl-1,3-oxazol-5-one Chemical class O1C(=O)C(=C/OCC)\N=C1C1=CC=CC=C1 SJHPCNCNNSSLPL-CSKARUKUSA-N 0.000 title 1
- 241000590002 Helicobacter pylori Species 0.000 title 1
- 229940037467 helicobacter pylori Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/48—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP16485496 | 1996-06-25 | ||
| JP9-25162 | 1997-02-07 | ||
| JP8-164854 | 1997-02-07 | ||
| JP2516297 | 1997-02-07 | ||
| PCT/JP1997/002157 WO1997049703A2 (en) | 1996-06-25 | 1997-06-24 | Oxazolone derivatives and their use as anti-helicobacter pylori agents |
| ZA978876A ZA978876B (en) | 1996-06-25 | 1997-10-03 | Oxazolone derivatives and their use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU3191397A true AU3191397A (en) | 1998-01-14 |
Family
ID=27284916
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU31913/97A Abandoned AU3191397A (en) | 1996-06-25 | 1997-06-24 | Oxazolone derivatives and their use as anti-(helicobacter pylori) agent |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0923577A2 (en) |
| CN (1) | CN1077892C (en) |
| AU (1) | AU3191397A (en) |
| CA (1) | CA2248784A1 (en) |
| WO (1) | WO1997049703A2 (en) |
| ZA (1) | ZA978876B (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4929899A (en) * | 1998-07-30 | 2000-02-21 | Takeda Chemical Industries Ltd. | Process for producing indolemycin |
| KR20020038759A (en) | 1999-10-20 | 2002-05-23 | 다니구치 미즈오 | Method for stabilizing benzimidazole compounds |
| PT1696920E (en) | 2003-12-19 | 2015-01-14 | Plexxikon Inc | Compounds and methods for development of ret modulators |
| US7498342B2 (en) | 2004-06-17 | 2009-03-03 | Plexxikon, Inc. | Compounds modulating c-kit activity |
| US7371862B2 (en) | 2005-11-11 | 2008-05-13 | Pfizer Italia S.R.L. | Azaindolylidene derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| WO2008063888A2 (en) | 2006-11-22 | 2008-05-29 | Plexxikon, Inc. | Compounds modulating c-fms and/or c-kit activity and uses therefor |
| SG183036A1 (en) | 2007-07-17 | 2012-08-30 | Plexxikon Inc | Compounds and methods for kinase modulation, and indications therefor |
| AU2010232670B2 (en) | 2009-04-03 | 2015-07-09 | F. Hoffmann-La Roche Ag | Propane- I-sulfonic acid {3- [5- (4 -chloro-phenyl) -1H-pyrrolo [2, 3-b] pyridine-3-carbonyl] -2, 4-difluoro-pheny l } -amide compositions and uses thereof |
| ES2633317T3 (en) | 2009-11-06 | 2017-09-20 | Plexxikon, Inc. | Compounds and methods for kinase modulation, and indications for it |
| CN103517710B (en) | 2011-02-07 | 2017-05-31 | 普莱希科公司 | For the compound of kinases regulation |
| TWI558702B (en) | 2011-02-21 | 2016-11-21 | 普雷辛肯公司 | Solid forms of a pharmaceutically active substance |
| JP6113151B2 (en) | 2011-05-17 | 2017-04-12 | プレキシコン インコーポレーテッドＰｌｅｘｘｉｋｏｎ Ｉｎｃ． | Kinase regulation and its indications |
| US9358235B2 (en) | 2012-03-19 | 2016-06-07 | Plexxikon Inc. | Kinase modulation, and indications therefor |
| US9150570B2 (en) | 2012-05-31 | 2015-10-06 | Plexxikon Inc. | Synthesis of heterocyclic compounds |
| WO2021133037A1 (en) * | 2019-12-26 | 2021-07-01 | 연세대학교 산학협력단 | Pyrrolidine derivative, and pharmaceutical composition for preventing or treating beta-amyloid or tau protein-associated diseases containing same |
| CN113480544B (en) * | 2021-07-09 | 2022-04-26 | 成都大学 | A kind of alkynylated imidazo[1,5-a]indole compound and preparation method thereof |
| CN116159054B (en) * | 2021-11-25 | 2025-07-08 | 中国医学科学院医药生物技术研究所 | Application of neomycin in inhibiting pathogenic bacteria of digestive tract |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US458385A (en) * | 1891-08-25 | Heater | ||
| GB862685A (en) * | 1956-11-02 | 1961-03-15 | Pfizer & Co C | New antibiotic designated pa 155a |
| US3173923A (en) * | 1961-04-13 | 1965-03-16 | Pfizer & Co C | 1-(3'-indolyl)-1-[5"-(2''-methylimino)-4''-ketooxazolidinyl] ethane and acid addition salts thereof |
| US3320282A (en) * | 1962-10-29 | 1967-05-16 | Pfizer & Co C | Process for preparing esters of 2-hydroxy-3-(3-indolyl) alkanoic acids |
| US4584385A (en) * | 1984-03-22 | 1986-04-22 | Pfizer Inc. | Antibacterial 2-amino-oxazolinones and process therefor |
| US5607932A (en) * | 1994-07-12 | 1997-03-04 | Janssen Pharmaceutica N.V. | Heterocyclic derivatives of azolones |
-
1997
- 1997-06-24 AU AU31913/97A patent/AU3191397A/en not_active Abandoned
- 1997-06-24 CA CA002248784A patent/CA2248784A1/en not_active Abandoned
- 1997-06-24 WO PCT/JP1997/002157 patent/WO1997049703A2/en not_active Ceased
- 1997-06-24 EP EP97927428A patent/EP0923577A2/en not_active Withdrawn
- 1997-06-24 CN CN97195506A patent/CN1077892C/en not_active Expired - Fee Related
- 1997-10-03 ZA ZA978876A patent/ZA978876B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2248784A1 (en) | 1997-12-31 |
| WO1997049703A2 (en) | 1997-12-31 |
| EP0923577A2 (en) | 1999-06-23 |
| CN1230958A (en) | 1999-10-06 |
| CN1077892C (en) | 2002-01-16 |
| ZA978876B (en) | 1999-06-30 |
| WO1997049703A3 (en) | 1998-02-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU3767097A (en) | Shampoo compositions and method | |
| AU7243398A (en) | Cross-platform computer architecture and components thereof | |
| AU7718898A (en) | Txu-7-pap immunotoxin and use thereof | |
| AU3191397A (en) | Oxazolone derivatives and their use as anti-(helicobacter pylori) agent | |
| AU2829995A (en) | Detection of helicobacter pylori | |
| AU2952997A (en) | Thiocyano-triazolyl derivatives and their use as microbicides | |
| AU2896597A (en) | Sulphonyl-mercapto-triazolyl derivatives and their use as microbicides | |
| AU2769697A (en) | Benzofuryl derivatives and their use | |
| ZA971964B (en) | Azolobenzazepine derivatives and compositions and method of use thereof. | |
| AU1136297A (en) | Methods and compositions for diagnosis of hyperhomocysteinemia | |
| AU3352197A (en) | Pyridyl-piperazinyl-phenyl-oxazolidinone derivatives and their use as antibacterials | |
| AU5856898A (en) | Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them | |
| AU2932197A (en) | Benzothiophenes, formulations containing same, and methods | |
| AU3701397A (en) | Anti-herpesviral agent | |
| AU3472799A (en) | Dermatological formulations and methods | |
| AU2670897A (en) | Fibulin pharmaceutical compositions and related methods | |
| AU2126495A (en) | Recombinase-deficient (helicobacter pylori) and related methods | |
| AU2664797A (en) | Wnt receptor compositions and methods | |
| AU2215497A (en) | Benzothiophenes, formulations containing same, and methods | |
| AU5160596A (en) | Helicobacter pylori cagi region | |
| AUPO982097A0 (en) | Methods and compositions for use therein | |
| AU1572297A (en) | Monoglyceride compositions and their use against helicobacter | |
| AU1698899A (en) | N-acetylserotonin derivatives and uses thereof | |
| AU3107497A (en) | Asialotrisaccharide moranoline derivatives and drugs | |
| AU1724697A (en) | Novel aminophenol derivatives and their use |